SIC 283 – Drugs
| Valuation | |
|---|---|
| Market Cap ($M) | 18,451.21 |
| Enterprise Value ($M) | 20,636.21 |
| Book Value ($M) | 7,790.00 |
| Book Value / Share | 32.81 |
| Price / Book | 2.37 |
| NCAV ($M) | -2,984.00 |
| NCAV / Share | -12.57 |
| Price / NCAV | -6.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.02 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.94 |
| Current Ratio | 1.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,843.00 |
| Assets | 12,617.00 |
| Liabilities | 4,827.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 4,440.00 |
| Operating Income | 671.00 |
| Net Income | 231.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 488.00 |
| Cash from Investing | -326.00 |
| Cash from Financing | -58.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| FTII – FutureTech II Acquisition Corp. | GBIM – GlobeImmune, Inc. |
| GCAN – The Greater Cannabis Company, Inc. | GFOO – Genufood Energy Enzymes Corp. |
| GIFLF – Grifols, S.A. |
Financial data and stock pages provided by
Fintel.io